Expertise in
9
conditions

Paul J. Young

405 Liverpool Street, 
Darlinghurst, NSW, AU 
Expertise in
9
conditions
405 Liverpool Street, 
Darlinghurst, NSW, AU 

Overview

Paul Young practices practicing medicine in Darlinghurst, Australia.

Mr. Young is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Sepsis, Peptic Ulcer, Cardiac Arrest, and Hypothermia.

He is actively involved in clinical research, co-authoring 452 peer reviewed articles and participating in 7 clinical trials.

Gender

Male

Locations

405 Liverpool Street, Darlinghurst, NSW 2010, Australia
Other Locations
Robin Warren Drive, Murdoch, WA 6150, Australia
306 Carmody Road, Brisbane, QLD 4072, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

STandard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI): A Multi-Centre, Randomized, Controlled Trial (Principal Trial)
STandard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI): A Multi-Centre, Randomized, Controlled Trial (Principal Trial)
Enrollment Status: Completed
Publish Date: October 18, 2024
Intervention Type: Other
Study Phase: Not Applicable
A Prospective Multicentre Phase III Randomised Controlled Trial of Early Activity and Mobilisation Compared With Standard Care in Invasively Ventilated Patients in Intensive Care
A Prospective Multicentre Phase III Randomised Controlled Trial of Early Activity and Mobilisation Compared With Standard Care in Invasively Ventilated Patients in Intensive Care
Enrollment Status: Completed
Publish Date: December 18, 2023
Intervention Type: Behavioral
Study Phase: Phase 3
A Phase III Randomised Controlled Trial of Continuous Beta-lactam Infusion Compared With Intermittent Beta-lactam Dosing in Critically Ill Patients
A Phase III Randomised Controlled Trial of Continuous Beta-lactam Infusion Compared With Intermittent Beta-lactam Dosing in Critically Ill Patients
Enrollment Status: Completed
Publish Date: December 12, 2023
Intervention Type: Other
Study Phase: Not Applicable
Comparison of Plasmalyte 148® and Saline for Fluid Resuscitation and Intravenous Fluid Therapy in Critically Ill Adults
Comparison of Plasmalyte 148® and Saline for Fluid Resuscitation and Intravenous Fluid Therapy in Critically Ill Adults
Enrollment Status: Completed
Publish Date: August 08, 2023
Intervention Type: Drug
Study Phase: Phase 4
TAME Cardiac Arrest Trial: Targeted Therapeutic Mild Hypercapnia After Resuscitated Cardiac Arrest: A Phase III Multi-Centre Randomised Controlled Trial
TAME Cardiac Arrest Trial: Targeted Therapeutic Mild Hypercapnia After Resuscitated Cardiac Arrest: A Phase III Multi-Centre Randomised Controlled Trial
Enrollment Status: Unknown
Publish Date: April 20, 2022
Intervention Type: Other
Study Phase: Not Applicable
An International, Multi-centre, Randomized Controlled Trial to Assess Transfusion Thresholds in Patients Undergoing Cardiac Surgery
An International, Multi-centre, Randomized Controlled Trial to Assess Transfusion Thresholds in Patients Undergoing Cardiac Surgery
Enrollment Status: Completed
Publish Date: August 15, 2018
Intervention Type: Other
Study Phase: Not Applicable
A Randomised Blinded Placebo Controlled Trial of Hydrocortisone in Critically Ill Patients With Septic Shock
A Randomised Blinded Placebo Controlled Trial of Hydrocortisone in Critically Ill Patients With Septic Shock
Enrollment Status: Completed
Publish Date: December 12, 2017
Intervention Type: Drug
Study Phase: Phase 4
View 6 Less Clinical Trials

451 Total Publications

What is estimated in cluster randomized crossover trials with informative sizes? A survey of estimands and common estimators.
What is estimated in cluster randomized crossover trials with informative sizes? A survey of estimands and common estimators.
Journal: Statistical methods in medical research
Published: August 08, 2026

Frequently Asked Questions about Paul J. Young

Is Paul J. Young a top-rated expert for Sepsis?

MediFind is an objective health platform that identifies experts based on real-world data. Paul J. Young is classified as an Distinguished expert for Sepsis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Paul J. Young participate in research or clinical trials?

Yes. Paul J. Young has published 451 articles and abstracts on conditions like Sepsis. You can view a list of Paul J. Young's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Young's expertise for a condition
ConditionClose
    View All 29 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile